Hawaii SB2390 mandates insurance coverage for biomarker testing for diagnosis, treatment, and monitoring of diseases.

Hawaii SB2390 amends state statutes to require insurance coverage for biomarker testing, effective January 1, 2027. Biomarker testing includes analysis of tissue, blood, or other biospecimens for gene mutations, gene characteristics, and protein expression. The coverage applies to individual and group policies of accident and health or sickness insurance, as well as hospital or medical service plan contracts. The bill also mandates that insurers provide a process for requesting exceptions if coverage is restricted.

Hawaii SB2390 mandates insurance coverage for biomarker testing for diagnosis, treatment, and monitoring of diseases.

Hawaii SB2390 amends state statutes to require insurance coverage for biomarker testing, effective January 1, 2027. Biomarker testing includes analysis of tissue, blood, or other biospecimens for gene mutations, gene characteristics, and protein expression. The coverage applies to individual and group policies of accident and health or sickness insurance, as well as hospital or medical service plan contracts. The bill also mandates that insurers provide a process for requesting exceptions if coverage is restricted.